RETA 30 mg
Advanced Triple-Action Weight Loss Injection
Harnessing three pathways (GLP-1, GIP, and glucagon) for maximum weight-loss efficacy
What is RETA 30 mg?
RETA 30 mg is a next-generation weight-loss injection that activates three hormonal pathways. This triple-agonist formula is inspired by cutting-edge research and is designed to amplify weight loss beyond traditional treatments.
By engaging the receptors for GLP-1 and GIP (which control appetite and insulin) and the glucagon receptor (which aids in fat burning and metabolism), RETA offers a comprehensive approach to weight reduction. This class of treatment has shown remarkable results in clinical trials – patients have achieved significantly greater weight loss compared to single or dual agonists, with studies showing up to 28% body weight reduction.
How RETA Works: Triple-Pathway Mechanism
RETA medication simultaneously targets all three pathways, tackling weight loss from multiple angles:
GLP-1 Pathway
Reduces appetite and slows digestion, so you eat less and feel full longer.
GIP Pathway
Works with GLP-1 to further improve insulin release and contributes to satiety.
Glucagon Pathway
Signals the body to release and burn stored energy, promoting fat breakdown and increasing metabolic rate.
Think of it as combination therapy in one injection – controlling hunger while also encouraging the body to burn fat more efficiently. This triple-action may lead to greater weight loss and metabolic improvements than focusing on a single pathway.
Benefits of RETA 30 mg
Maximum Weight Loss Potential
By leveraging three pathways, RETA could help achieve 25-30% body weight reduction.
Comprehensive Control
Dramatic appetite suppression plus increased calorie burning.
Metabolic Health Improvements
Improved blood sugar levels, liver health, and overall metabolic function.
Once-Weekly Dosing
Just a single weekly injection despite its powerful effects.
Slim Lab NI Support
Close monitoring of progress and well-being to ensure safe, optimal results.
Next-Generation Science
Based on the latest breakthrough research in obesity treatment.
Who is RETA For?
Eligibility & Suitability
RETA 30 mg is generally intended for adults with obesity (BMI ≥30, or ≥27 with weight-related health issues), and will be prescribed only after a thorough evaluation.
Due to its comprehensive effect, it's often considered for individuals who require substantial weight reduction or have not achieved desired results with other treatments. Our medical team will determine if RETA is the right choice for your specific situation.
Usage & Storage Instructions
Administration
- For subcutaneous use only (abdomen, thigh, upper arm)
- Multidose pen: 50 clicks = 5 mg dose
- Rx only – prescription required
- Dosing starts low and increases over time
Storage
- Store in refrigerator (2°C–8°C)
- Do not freeze
- Protect from light
- Keep in original case until used
- Discard after use as instructed
Side Effects & Safety
Common Side Effects
Similar to other GLP-1 treatments, common side effects include nausea, vomiting, diarrhea, or constipation – particularly during dose escalation. These effects usually ease over time.
Because RETA engages multiple pathways, careful monitoring is provided to manage any reactions and ensure safety. Our team closely monitors your progress and well-being throughout treatment.
Limited Availability – Contact Us About RETA 30 mg
Call us or WhatsApp to inquire about eligibility for RETA 30 mg. Our medical team will discuss whether this next-generation treatment is right for you.